Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 07 10 2018
accepted: 10 01 2019
pubmed: 2 2 2019
medline: 10 1 2020
entrez: 2 2 2019
Statut: ppublish

Résumé

Increased amyloid β (Aβ) aggregation is a hallmark feature of Alzheimer's disease (AD) pathology. The APP/PS1 mouse model of AD exhibits accumulation of Aβ in the retina and demonstrates reduced retinal function and other degenerative changes. The overall molecular effects of AD pathology on the retina remain undetermined. Using a proteomics approach, this study assessed the molecular effects of Aβ accumulation and progression of AD pathology on the retina. Retinal tissues from younger (2.5 months) and older 8-month APP/PS1 mice were analysed for protein expression changes. A multiplexed proteomics approach using chemical isobaric tandem mass tags was applied followed by functional and protein-protein interaction analyses using Ingenuity pathway (IPA) and STRING computational tools. We identified approximately 2000 proteins each in the younger (upregulated 50; downregulated 36) and older set of APP/PS1 (upregulated 85; downregulated 79) mice retinas. Amyloid precursor protein (APP) was consistently upregulated two to threefold in both younger and older retinas (p < 0.0001). Mass spectrometry data further revealed that older APP/PS1 mice retinas had elevated levels of proteolytic enzymes cathepsin D, presenilin 2 and nicastrin that are associated with APP processing. Increased levels of proteasomal proteins Psma5, Psmd3 and Psmb2 were also observed in the older AD retinas. In contrast to the younger animals, significant downregulation of protein synthesis and elongation associated proteins such as Eef1a1, Rpl35a, Mrpl2 and Eef1e1 (p < 0.04) was identified in the older mice retinas. This study reports for the first time that not only old but also young APP/PS1 animals demonstrate increased amyloid protein levels in their retinas. Quantitative proteomics reveals new molecular insights which may represent a cellular response to clear amyloid build-up. Further, downregulation of ribosomal proteins involved in protein biosynthesis was observed which might be considered a toxicity effect.

Identifiants

pubmed: 30707393
doi: 10.1007/s12035-019-1479-4
pii: 10.1007/s12035-019-1479-4
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
Presenilin-1 0
alpha-Crystallin B Chain 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6017-6034

Subventions

Organisme : National Health and Medical Research Council
ID : 1084767
Organisme : Macquarie University
ID : 5016420
Organisme : The Ophthalmic Research Institute of Australia
ID : 9201400700

Références

J Neurosci. 2000 Jun 1;20(11):3937-46
pubmed: 10818128
Neuropathol Appl Neurobiol. 2001 Jun;27(3):180-8
pubmed: 11489137
J Neurochem. 2003 Apr;85(1):115-22
pubmed: 12641733
Neuroscience. 2005;131(4):877-86
pubmed: 15749342
Biol Chem. 2005 Sep;386(9):931-40
pubmed: 16164418
J Neurosci. 2005 Oct 5;25(40):9171-5
pubmed: 16207876
Neurobiol Dis. 2006 Apr;22(1):76-87
pubmed: 16378731
EMBO Rep. 2006 Sep;7(9):940-6
pubmed: 16906128
Mol Cell Proteomics. 2007 May;6(5):895-907
pubmed: 17264069
Invest Ophthalmol Vis Sci. 2007 May;48(5):2285-9
pubmed: 17460292
J Neurosci Res. 2008 May 1;86(6):1343-52
pubmed: 18061943
J Biol Chem. 2008 Mar 21;283(12):7745-53
pubmed: 18184658
Glia. 2008 Apr;56(5):552-67
pubmed: 18240300
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5136-43
pubmed: 18566467
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):793-800
pubmed: 18791173
Science. 2009 May 1;324(5927):639-42
pubmed: 19299585
Neurobiol Aging. 2011 Mar;32(3):419-33
pubmed: 19356824
PLoS One. 2009 Oct 14;4(10):e7454
pubmed: 19829701
Am J Pathol. 2009 Nov;175(5):2099-110
pubmed: 19834067
PLoS One. 2010 Mar 22;5(3):e9764
pubmed: 20339537
EMBO Rep. 2010 Nov;11(11):861-7
pubmed: 20890309
Neurobiol Aging. 2011 Dec;32(12):2324.e1-6
pubmed: 20970889
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Age (Dordr). 2012 Jun;34(3):633-49
pubmed: 21559868
J Biol Chem. 2011 Sep 9;286(36):31153-8
pubmed: 21768095
Biophys J. 2011 Oct 5;101(7):1681-9
pubmed: 21961594
Brain Pathol. 2012 Sep;22(5):636-53
pubmed: 22188425
Arch Gen Psychiatry. 2012 Jan;69(1):98-106
pubmed: 22213792
Am J Physiol Endocrinol Metab. 2012 Dec 1;303(11):E1363-72
pubmed: 23032687
Alzheimers Dement. 2013 Jan;9(1):e-1-16
pubmed: 23360977
Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):871-80
pubmed: 23364356
Neurology. 2013 May 7;80(19):1778-83
pubmed: 23390181
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Mol Neurobiol. 2013 Dec;48(3):819-28
pubmed: 23709342
Neurosci Lett. 2013 Sep 13;551:12-6
pubmed: 23810804
Aging Cell. 2013 Dec;12(6):1032-40
pubmed: 23826707
J Alzheimers Dis. 2013;37(4):699-712
pubmed: 23948910
Mitochondrion. 2013 Nov;13(6):566-76
pubmed: 23993956
Biochim Biophys Acta. 2014 Sep;1842(9):1556-66
pubmed: 24887203
J Alzheimers Dis. 2014;42(3):739-55
pubmed: 24946876
J Alzheimers Dis. 2015;45(2):495-507
pubmed: 25589714
Exp Mol Med. 2015 Mar 13;47:e147
pubmed: 25766616
EuPA Open Proteom. 2015 Jun;7:11-19
pubmed: 25821719
Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):278-86
pubmed: 26049079
Brain Pathol. 2016 Sep;26(5):593-605
pubmed: 26512942
Alzheimers Dement. 2016 Apr;12(4):373-9
pubmed: 26588863
J Neurosci. 2016 Jan 20;36(3):1001-7
pubmed: 26791227
Sci Rep. 2016 Mar 03;6:22460
pubmed: 26936520
Neurosci Lett. 2016 Jun 3;623:52-6
pubmed: 27133194
Oncotarget. 2016 Jun 7;7(23):33627-48
pubmed: 27144524
J Neurosci. 2016 May 25;36(21):5785-98
pubmed: 27225768
Cell Mol Life Sci. 2016 Nov;73(22):4279-4297
pubmed: 27333888
J Alzheimers Dis. 2016 Sep 6;54(2):763-76
pubmed: 27567864
Acta Neuropathol. 2016 Dec;132(6):767-787
pubmed: 27645291
J Neuroimmune Pharmacol. 2017 Jun;12(2):340-352
pubmed: 27966067
Neurobiol Sleep Circadian Rhythms. 2017 Jan;2:4-14
pubmed: 28217760
Alzheimers Res Ther. 2017 Mar 1;9(1):13
pubmed: 28253913
PLoS One. 2017 Apr 6;12(4):e0175451
pubmed: 28384305
Am J Pathol. 2017 Jul;187(7):1601-1612
pubmed: 28500862
Am J Neurodegener Dis. 2017 Jun 15;6(2):15-25
pubmed: 28695061
JCI Insight. 2017 Aug 17;2(16):null
pubmed: 28814675
Sci Rep. 2017 Aug 21;7(1):8412
pubmed: 28827627
Lancet Neurol. 2017 Nov;16(11):877-897
pubmed: 28931491
Neuroscience. 2017 Nov 19;364:175-189
pubmed: 28947394
Nat Commun. 2017 Sep 25;8(1):693
pubmed: 28947735
Sci Rep. 2017 Oct 4;7(1):12685
pubmed: 28978942
Neurobiol Aging. 2018 Jul;67:181-188
pubmed: 29735432
Ann Neurol. 2018 Jul;84(1):78-88
pubmed: 29908079
Mol Ther. 2019 Feb 6;27(2):424-441
pubmed: 30341011
Vision Res. 1972 Jun;12(6):1183-98
pubmed: 5043568
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1550-5
pubmed: 9037091

Auteurs

Mehdi Mirzaei (M)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia. mehdi.mirzaei@mq.edu.au.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia. mehdi.mirzaei@mq.edu.au.
Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia. mehdi.mirzaei@mq.edu.au.

Kanishka Pushpitha (K)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Liting Deng (L)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.

Nitin Chitranshi (N)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Veer Gupta (V)

School of Medicine, Deakin University, Melbourne, VIC, Australia.

Rashi Rajput (R)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Abu Bakr Mangani (AB)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Yogita Dheer (Y)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Angela Godinez (A)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Matthew J McKay (MJ)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.

Karthik Kamath (K)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.

Dana Pascovici (D)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.

Jemma X Wu (JX)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.

Ghasem Hosseini Salekdeh (GH)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
Department of Molecular Systems Biology, Cell Science Research Center, Royan, Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Tim Karl (T)

School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Paul A Haynes (PA)

Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.

Stuart L Graham (SL)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Vivek K Gupta (VK)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia. vivek.gupta@mq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH